Use of Human Dehydrated Amnion/Chorion (DHACM) Allograft in Partial Nephrectomy

Kidney Cancer Clinical Trial

Official title: A Single-Center Double Arm Single-Blinded Randomized Screening Clinical Trial to Evaluate the Use of Human Dehydrated Amnion/Chorion Membrane to Facilitate the Recovery of Renal Function Following Robotic Partial Nephrectomy

Status Completed

Clinical Trial Summary

After partial nephrectomy, kidney function decreases by about 10% overall and by about 20% in the operated kidney. This is primarily due to the loss of healthy parenchymal volume during resection of the tumor. In an effort to preserve and regenerate healthy parenchyma during the procedure and ultimately renal function after partial nephrectomy, the single center double arm single-blinded randomized screening clinical trial will evaluate the ability of human amnion/chorion allograft to facilitate the recovery of renal function following robotic partial nephrectomy.

Clinical Trial Description

To determine whether Amniofix facilitates improved recovery of renal function at 12 months. ;

Related Conditions & MeSH terms

• Dehydration
• Kidney Cancer
• Kidney Neoplasms
• Partial Nephrectomy
• Renal Function Aggravated

• NCT number: NCT03323021
• Study type: Interventional
• Source: MiMedx Group, Inc.
• Status: Completed
• Phase: N/A
• Start date: May 23, 2017
• Completion date: February 21, 2019